SCHEMBL3723910

SCHEMBL3723910

CCCCNS(=O)(=O)c1ccccc1S(N)(=O)=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.63
CA12 O43570 3/20 0.61
CA9 Q16790 3/20 0.61
ALDH1A1 P00352 7/20 0.51
TSHR P16473 4/20 0.51
CYP1A2 P05177 3/20 0.50
CYP3A4 P08684 3/20 0.50
CYP2C19 P33261 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TP53 P04637 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CA2 P00918 2/20 0.48
CA1 P00915 1/20 0.48
KDM4E B2RXH2 4/20 0.46
HSD17B10 Q99714 3/20 0.46
SCN1A P35498 2/20 0.46
SCN2A Q99250 2/20 0.46
SCN3A Q9NY46 2/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2229994 0.83 RECQL (0.88) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL9738489 0.83 CA12 (0.66) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL18989501 0.83 CA9 (0.61) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL31391062 0.81 CA12 (0.63) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL9462811 0.81 CA12 (0.63) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL635553 0.81 CA12 (0.63) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL9738480 0.81 CA12 (0.63) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL13296442 0.80 CYP3A4 (0.65) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL3978111 0.80 CA12 (0.61) RECQLCA12CA9ALDH1A1TSHR
SCHEMBL7111715 0.79 CA12 (0.67) RECQLCA12CA9ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010132016-A1 BIS-(SULFONYLAMINO) DERIVATIVES FOR TREATMENT OF PAIN AND INFLAMMATION ASTRAZENECA AB (SE) 2010-11-18 WO disclosed